Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

External application medicine for treating hypertension

A technology for external use of drugs and hypertension, applied in the field of external use of drugs for the treatment of high blood pressure, can solve the problems of poor blood flow, thickening of blood vessel walls, low treatment rate and control rate, etc., to restore the blood pressure regulation mechanism and restore physiological functions. , Remarkable and reliable effect

Inactive Publication Date: 2007-09-26
谭怀志
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It can be seen from the above statistics that the prevalence of hypertension in my country is increasing, but the treatment rate and control rate are very low, which forms a huge contrast. The main reason for the low treatment rate of hypertension in my country may be : 1. People and people suffering from high blood pressure still don't know enough about the disease of high blood pressure
2. Lack of effective therapeutic drugs
4. Long-term treatment brings great psychological and family financial burdens to individuals, and long-term medication also brings great troubles to patients
5. The toxic side effects or complications caused by many drugs make patients afraid of treatment
6. The impact of some false propaganda, such as saying that a certain medicine can cure all diseases, that a certain medicine can be cured once, and it can be eradicated after two treatments (it is actually impossible for this disease), etc., to be too alarmist False propaganda, causing headaches and confusion to patients, or loss of confidence
3. Defects in cell membrane function, such as decreased elasticity of vascular endothelium, increased tissue hydrostatic pressure, and abnormal calcium metabolism
5. Thickening of blood vessel wall, narrowing of lumen, poor blood flow
[0010] In summary, at present, the effects of Chinese and Western medicines for treating hypertension are not satisfactory, and there are many toxic and side effects (especially western medicines). The short-term and long-term curative effects are ideal, and there is no or very little side effect, easy to use, safe and reliable new preparation, which is the desire of the majority of patients and the urgent need of clinical practice.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0053] Example 1: Wang ××, male, 56 years old, first visit on March 6, 1992. Private prosecution: 12 years ago, due to dizziness, headache, and poor sleep, I checked in the hospital, measured blood pressure: 165 / 106mmHg, and was diagnosed as "essential hypertension". Since then, oral antihypertensive drugs have been taken. At first, compound Jiangyaling, compound radish, compound Danshen tablets, vitamin C, etc. were taken orally. After taking the medicine for more than 3 years, the effect was not satisfactory. After taking the above-mentioned drugs, the blood pressure can be stabilized in the normal range. Once the drug is stopped for more than 2 days, the blood pressure will rise (but not as high as before the initial diagnosis of hypertension), so I have never dared to stop the drug until I heard others talk about this therapy. After taking the medicine for many years, I received the treatment with a try. Before the treatment, the blood pressure was checked 3 times, 145-136...

example 2

[0055] Example 2: Zou ××, man, 59 years old, first visit on June 14, 2005. Self-report 5 years ago, the employee's physical examination of this unit showed blood pressure 160 / 100mmHg, and went to the hospital for examination after half a month, and was diagnosed as "essential hypertension". That is, oral antihypertensive drugs have been taken. For more than 5 years, if the blood pressure is still stable after taking the drugs, the blood pressure will rise again when the drugs are stopped. Use this method for treatment instead, measure blood pressure 135 / 90mmHg before treatment, with mild dizziness from time to time every day. The dizziness disappeared after the first application of the drug for 4 days. During the treatment, the blood pressure was 135-123 / 86-78mmHg, and the dressing was changed 10 times. The blood pressure was stable, and the drug was stopped for observation. Blood pressure was measured once a day, and once a month after 3 months. The measured blood pressure w...

example 3

[0056] Example 3: Liu ××, male, 69 years old. On May 15, 2006, I came to see a doctor through the introduction of others: I reported that I went to the hospital for dizziness, headache, and palpitation in April 2003, and my blood pressure was 180 / 110mmHg, and I was diagnosed as "hypertension with coronary heart disease". At that time, the hospital required hospital treatment, but because of work, he was unable to be hospitalized. The hospital outpatient prescribed betalock, felodipine and other medicines, and he also took panax notoginseng and hawthorn powder by himself. After a period of time, I felt that the cost was too expensive, so I changed to Niboda and Zhenju Jiangya Tablets, followed by Panax notoginseng and hawthorn powder. Stop oral antihypertensive drugs on the day of receiving this therapy. Before the treatment, the blood pressure was 145 / 88mmHg. After 10 times of application of medicine, the blood pressure was 140-125 / 83-70mmHg during the treatment. Stop treatm...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Disclosed is a Chinese medicament for treating hypertension which is prepared from the following raw materials: evodia rutaecarpa 10-90g, pinellia tuber 10-40g, hooked uncaria 10-80g, sulfur 10-35g, Loranthus mulberry mistletoe 10-42g, lodestone 10-48g, Ligusticum wallichii 10-90g, chrysanthemum flower 10-80g, wofberry bark 10-65g, kudzuvine root 10-80g, riddle 10-48g, cassia twig 10-26g, malt 10-33g, earthworm 10-80g, alisol 10-65g, rhubarb horsetails 10-65g, sphene 10-45g, soybean 10-90g, eucommia bark 10-80g, trogopterus dung 10-42g, cattail pollen 10-42g, haw 10-50g, areca-nut 10-42g, weeping-willow leaves 10-90g and nifedipine 2-3g.

Description

1. Technical field [0001] The invention relates to a medicine for external use for treating hypertension. 2. Background technology [0002] At present, hypertension is still a common clinical syndrome with unknown cause and mainly manifested by elevated systemic arterial pressure. Clinically, hypertension is divided into two types: primary and secondary. The former is called essential hypertension. , also known as simple hypertension, hypertension; the latter is called secondary hypertension, also known as symptomatic hypertension. In recent years, scholars have used systolic blood pressure (SP) ≥ 21.3KPa (165mmHg) and diastolic blood pressure (DP) ≥ 12.7KPa (95mmHg) as the criteria for diagnosing hypertension. In hypertensive patients, essential hypertension accounts for more than 90% of the population's incidence. [0003] In today's society, with the improvement of people's living standards, the accelerated or irregular pace of work and life, smoking, alcoholism, unreas...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/899A61P9/12A61K31/4422A61K31/138A61K33/00A61K33/04A61K33/26A61K35/24A61K35/64
Inventor 谭怀志谭懿谭雅元
Owner 谭怀志
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products